| COIIX | OSMCX | COIIX / OSMCX | |
| Total Expense Ratio | 1.09 | 2.13 | 51% |
| Annual Report Gross Expense Ratio | 1.09 | 2.13 | 51% |
| Fund Existence | 19 years | 28 years | - |
| Gain YTD | 10.394 | -5.673 | -183% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 318M | 2.59B | 12% |
| Annual Yield % from dividends | 2.87 | 0.47 | 606% |
| Returns for 1 year | 9.65 | -6.52 | -148% |
| Returns for 3 years | 23.65 | -12.24 | -193% |
| Returns for 5 years | -1.69 | -39.17 | 4% |
| Returns for 10 years | 45.15 | -15.34 | -294% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FTDZX | 179.25 | 1.27 | +0.71% |
| Franklin Biotechnology Discovery Adv | |||
| ALARX | 55.23 | 0.15 | +0.27% |
| Alger Capital Appreciation Instl I | |||
| JRAAX | 89.08 | 0.21 | +0.24% |
| Janus Henderson Research A | |||
| LMVWX | 29.10 | 0.03 | +0.10% |
| Lord Abbett Focused Small Cap Value R6 | |||
| PJRCX | 8.87 | N/A | N/A |
| PGIM Quant Solutions International Eq C | |||